Document Classification

Section Type: RESULTS

Text: During a median treatment duration of 4. 5 years, compared with the enalapril alone group, the enalapril-folic acid group had a significant risk reduction in first stroke (2. 7 % of participants in the enalapril-folic acid group vs 3. 4 % in the enalapril alone group ; hazard ratio [HR], 0. 79 ; 95 % CI, 0. 68-0. 93), first ischemic stroke (2. 2 % with enalapril-folic acid vs 2. 8 % with enalapril alone ; HR, 0. 76 ; 95 % CI, 0. 64-0. 91), and composite cardiovascular events consisting of cardiovascular death, MI, and stroke (3. 1 % with enalapril-folic acid vs 3. 9 % with enalapril alone ; HR, 0. 80 ; 95 % CI, 0. 69-0. 92).